NCT05224986 is a NA clinical trial of Fixed Schedule in Pre-diabetes, sponsored by Columbia University.

Who is sponsoring NCT05224986?

NCT05224986 is sponsored by Columbia University.

What drugs are being tested in NCT05224986?

Interventions in NCT05224986: Fixed Schedule.

What condition does NCT05224986 study?

NCT05224986 studies Pre-diabetes.

Is NCT05224986 still recruiting?

NCT05224986 is currently recruiting now. Last updated 28 January 2026.

Last reviewed 2026-01-28 · How we verify

NCT05224986

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Lifestyle Patterns and Glycemic Control

Recruiting now NA Last updated 28 January 2026

What this trial tests

NA trial testing Fixed Schedule in Pre-diabetes in 34 participants. Currently enrolling.

Timeline

19 January 2022

Primary endpoint
30 June 2026

31 July 2026

Quick facts

Lead sponsor	Columbia University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	34
Start date	19 January 2022
Primary completion	30 June 2026
Estimated completion	31 July 2026
Sites	1 location across United States

Drugs / interventions tested

Fixed Schedule

Conditions studied

Pre-diabetes — all drugs for Pre-diabetes →

Sponsor

Columbia University

Who can join

25 and older, any sex, with Pre-diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the proposed study is to evaluate the feasibility and initial efficacy of stabilizing lifestyle behaviors to improve glucose control and body composition in patients with pre-diabetes. The investigator proposes that following stable lifestyle behaviors will improve patients' glucose control, body composition, and liver fat. The results from this study has the potential to impact clinical practice and patient care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pre-diabetes

Currently open trials in the same condition.

NCT07189234 — Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health · Phase 2 · recruiting
NCT07079722 — More Health Less Diabetes · NA · recruiting
NCT07125365 — UK Islet Autoantibody Registry · recruiting
NCT06862128 — OGTT at Home Using CGM vs at the Clinic · NA · recruiting
NCT07021144 — VA|PREVENTION: Randomized Controlled Trial of a Person-Centred Digital Intervention to Prevent Diabetes in High-Risk Adu · NA · active not recruiting

Other Columbia University trials

Trials by the same sponsor.

NCT06558422 — Human Models of Selective Insulin Resistance: Pancreatic Clamp · Phase 1 · not yet recruiting
NCT07264582 — HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking · NA · not yet recruiting
NCT05992415 — Know Your Pressures NYC · NA · not yet recruiting
NCT05645211 — The AgRP and GH/IGF-1 Axis in Children · not yet recruiting
NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05224986 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Columbia University
Last refreshed: 28 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05224986.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing